DB14472InvestigationalProtein Based Therapies
The insulin-like growth factor II is a well-characterized neutral peptide believed to be secreted by the liver and to circulate in the blood. This factor presents effects related to growth... To perform its biological activities, this growth factor can present some dependence to somatotropin.
- Also known as
- Human insulin-like growth factor II · IGF-2 · IGF-II · Insulin-like growth factor 2 · Insulin-like growth factor II (human)
Resolves to
Compound
Clinical / RWD
What you can answer from here — as of April 02, 2025
Which companies are running trials of Insulin-like growth factor II, in which indications and phases, and which of those programs are still active?
Create a free account or log in to explore the full data card.
Create Account